LIVERPOOL, England--(BUSINESS WIRE)--EnXray Ltd, developers of innovative sterilization equipment, today announced that Robert Barlow has joined the senior management of the company as Commercial Director to support the pre-commercialization activities and launch of its ground breaking Low Energy X-ray (LEXR) sterilization equipment. The LEXR equipment enables on-site and on-demand sterilization of medical devices and consumables at the point of manufacture.
Robert joins EnXray following a successful 25-year career in commercial sales & marketing in the healthcare and medical device industry most recently at Covidien (now Medtronic) as well as with venture capital backed start-ups (e.g. Lynton Lasers and Microsulis Medical). Robert will be responsible for implementing EnXray’s commercialisation strategy, driving sales and developing customer relationships.
Ed Cappabianca, co-founder and CEO of EnXray, said: “Robert’s understanding of the global medical device industry and success building and leading teams capable of introducing new technology will be of great benefit to EnXray.”
Robert Barlow, Commercial Director, commented: “I am delighted to be joining EnXray at a time when markets are being disrupted by new and innovative services and solutions. Our LEXR System is one of those pioneering technologies that will challenge the status quo and create significant competitive advantages for our customers. We have an incredibly exciting journey ahead of us.”
EnXray will be at the XIVth Anglo Nordic Life Science Conference on Wednesday, 31st May 2017. Ed Cappabianca, CEO, will be presenting an overview on the Company’s technology and he and Robert Barlow will be available for meetings.
Visit www.enxray.com for more information.
Notes to editors
About EnXray Limited
EnXray Limited (EnXray) is a development-stage technology company founded in 2012, focused on commercializing its proprietary Low Energy X-rays (LEXR) technology for use in sterilization. EnXray’s first target market is the medical device manufacturing industry, where our technology will enable companies to manage and control the sterilization of their products (the final critical step of their production process) on-site & on-demand, providing significant benefits to its customers.
Today, the global medical device manufacturing industry relies upon large scale remote sterilization facilities, which creates significant logistics issues for manufacturers, as well as their end customers, such as hospitals and the NHS.
LEXR, or “soft x-rays” are a form of ionizing radiation in the range of 5 – 20 keV, which have some compelling characteristics, including a short transmission range through air, combined with a high absorption coefficient, which makes it a very efficient method for delivering high dosages of radiation in a relatively short period of time, without the need for extensive shielding. This is different from gamma-irradiation, where products have to be paletted in order to get reasonable sterilization efficacy, LEXR is designed for end-of-line processing and sterilization of individual products.
For further information please go to: http://www.enxray.com/news.html